Autoimmune bullous disease

Autoimmune Bullous Disease

Autoimmune bullous diseases are a group of rare, chronic disorders characterized by the presence of blisters and erosions on the skin and mucous membranes. These conditions are caused by an autoimmune response, where the body's immune system mistakenly attacks healthy tissue, specifically targeting proteins essential for skin integrity.

Pathophysiology

Autoimmune bullous diseases occur when the immune system produces antibodies against components of the skin's structure. The primary targets are proteins involved in cell adhesion, such as desmogleins in the case of pemphigus and components of the basement membrane zone in bullous pemphigoid. This immune attack leads to the separation of skin layers, resulting in blister formation.

Types of Autoimmune Bullous Diseases

• Pemphigus Vulgaris: This is the most common form of pemphigus, characterized by painful blisters and erosions on the skin and mucous membranes. It is caused by antibodies against desmoglein 3, a protein in the epidermis.

• Bullous Pemphigoid: A more common condition in the elderly, bullous pemphigoid presents with large, tense blisters that do not easily rupture. It involves antibodies against hemidesmosomal proteins BP180 and BP230.

• Dermatitis Herpetiformis: Associated with gluten sensitivity, this condition presents with intensely itchy blisters and is linked to antibodies against epidermal transglutaminase.

• Linear IgA Bullous Dermatosis: Characterized by linear deposits of IgA at the basement membrane, this condition can present with a variety of blistering patterns.

Diagnosis

Diagnosis of autoimmune bullous diseases involves a combination of clinical examination, histopathology, and immunofluorescence studies. Direct immunofluorescence of a skin biopsy is crucial, as it reveals the presence of specific antibodies in the skin. Indirect immunofluorescence and ELISA tests can detect circulating antibodies in the blood.

Treatment

Treatment aims to reduce inflammation, suppress the immune response, and promote healing of the skin. Common treatments include:

• Corticosteroids: These are the mainstay of treatment to quickly reduce inflammation and blister formation.

• Immunosuppressants: Drugs such as azathioprine, mycophenolate mofetil, and cyclophosphamide are used to reduce the immune system's activity.

• Biologics: Rituximab, a monoclonal antibody targeting CD20 on B cells, has shown efficacy in treating pemphigus vulgaris.

• Dapsone: Particularly effective in dermatitis herpetiformis and linear IgA bullous dermatosis.

Prognosis

The prognosis of autoimmune bullous diseases varies depending on the type and severity of the condition. With appropriate treatment, many patients can achieve remission, although long-term therapy may be necessary to maintain disease control.

Also see

• Pemphigus
• Bullous pemphigoid
• Dermatitis herpetiformis
• Immunofluorescence
• Autoimmune disease

Dermatology and Rheumatologic diseases A - Z

A | B | C | E | F | G | H | I | J | K | L | M | O | P | R | S | T | V

Glossary of dermatology